
GRML vs JSPR
$GRML vs $JSPR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GRML vs JSPR: the quick read
- ·GRML is the larger company by market cap ($45M vs $19M).
- ·GRML has been more active on our scanner (467 vs 11 alerts in 30 days).
- ·GRML has the smaller float (7.6M vs 27.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·JSPR trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·GRML draws far more of our scanner's attention, 467 unusual-volume alerts in 30 days against 11, so it is the more actively traded of the two by some distance.
- ·They are pulling apart today: JSPR is outperforming the other by roughly 10.9 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GRML and JSPR on TheDesperateTrader.
- Is GRML or JSPR the better stock?
- "Better" depends on your goal, and these two are not alike. GRML is the larger company by market cap ($45M vs $19M). GRML has been more active on our scanner (467 vs 11 alerts in 30 days). GRML has the smaller float (7.6M vs 27.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GRML and JSPR?
- The differences that matter: they are not in the same business - GRML is biological products, (no diagnostic substances) and JSPR is biological products, (no diagnostic substances); they are similar in size ($45M vs $19M); they trade at very different share prices ($5.35 vs $0.57); GRML sits at 29% of its 52-week range against 11% for JSPR; our scanner flagged GRML 467 times in the last 30 days against 11 for JSPR. Everything above is measured from the latest completed session and SEC filings.
- Which of GRML and JSPR is more active right now?
- Right now GRML is at about 0.1x its normal volume and JSPR is at about 1.1x, so JSPR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GRML or JSPR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GRML and JSPR comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.